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Background: Genomic reprogramming is thought to be, at least in part, responsible for the protective effect of
brain preconditioning. Unraveling mechanisms of this endogenous neuroprotection, activated by preconditioning,
is an important step towards new clinical strategies for treating asphyctic neonates.
Therefore, we investigated whole-genome transcriptional changes in the brain of rats which underwent perinatal
asphyxia (PA), and rats where PA was preceded by fetal asphyctic preconditioning (FAPA). Offspring were sacrificed
6 h and 96 h after birth, and whole-genome transcription was investigated using the Affymetrix Gene1.0ST chip.
Microarray data were analyzed with the Bioconductor Limma package. In addition to univariate analysis, we
performed Gene Set Enrichment Analysis (GSEA) in order to derive results with maximum biological relevance.
Results: We observed minimal, 25% or less, overlap of differentially regulated transcripts across different
experimental groups which leads us to conclude that the transcriptional phenotype of these groups is largely
unique. In both the PA and FAPA group we observe an upregulation of transcripts involved in cellular stress.
Contrastingly, transcripts with a function in the cell nucleus were mostly downregulated in PA animals, while we
see considerable upregulation in the FAPA group. Furthermore, we observed that histone deacetylases (HDACs)
are exclusively regulated in FAPA animals.
Conclusions: This study is the first to investigate whole-genome transcription in the neonatal brain after PA alone,
and after perinatal asphyxia preceded by preconditioning (FAPA). We describe several genes/pathways, such as
ubiquitination and proteolysis, which were not previously linked to preconditioning-induced neuroprotection.
Furthermore, we observed that the majority of upregulated genes in preconditioned animals have a function in the
cell nucleus, including several epigenetic players such as HDACs, which suggests that epigenetic mechanisms are
likely to play a role in preconditioning-induced neuroprotection.
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Perinatal asphyxia (PA) is a major cause of neonatal
mortality and is still the 2nd largest cause of death
among neonates worldwide [1]. Survivors often suffer
permanent neurological deficits, such as motor disabil-
ities, learning and cognitive problems [2]. The only
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article, unless otherwise stated.asphyxiated infants currently available is post-asphyctic
hypothermia. However, only a subset of patients benefit
from this strategy. Therefore, there is an urgent need to
develop additional neuroprotective strategies that may,
whether or not combined with hypothermia, provide an
even better neurological outcome [3].
Several experimental pharmacologic therapeutic strat-
egies were developed to prevent deleterious effects of
perinatal asphyxia, such as the anti-oxidant allopurinol
which should reduce free radical damage, and blockage
of NMDA-receptors with magnesium which should pre-
vent excitotoxicity. Although results in animal modelsentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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a favorable outcome with these treatments [4].
A different promising approach is studying endogenous
brain protection provided by the physiological pheno
menon of preconditioning. It was first described in the
brain in 1964 with a report of prolonged survival in rats
who underwent brief anoxia before a second anoxia period
[5]. The primary sublethal hypoxic-ischemic event is called
the preconditioning stimulus, and exposure to such a
stimulus induces endogenous neuroprotective mechanisms
[6]. However, the underlying mechanisms governing this
phenomenon have not been fully elucidated yet. Insight
into these mechanisms could provide us with directions for
future neuroprotective strategies. It has been suggested that
genomic reprogramming can explain a large part of these
mechanisms and genome-wide microarray technology pro-
vides an excellent tool to investigate this neuroprotective
reprogramming in experimental models [7].
So far, several studies have investigated large scale gene
expression with microarray technology after preconditioningFigure 1 Representative photomicrographs of Cleaved Caspase-3 stai
preconditioning and perinatal asphyxia (FAPA) combined. A1, B1, C1: overvie
A3, B3, C3: CA1 region at 10x magnification.in the newborn or adult brain [8-11]. However, different
experimental paradigms were used and, considering
that no paradigm incorporated the fetal-to-neonatal tran-
sition, none of these truly resembles the global impact of
PA and unique physiological mechanisms specific to the
time of birth are missed.
Here we present a whole-genome microarray study in a
previously validated model where we combine a global PA
insult at the time of birth, with fetal asphyctic (FA) pre-
conditioning on embryonic day 17 (E17). In this experi-
mental model we have previously shown that for animals
subjected to PA, FA preconditioning results in better
survival, no abnormal apoptosis in the brain at P8, and no
abnormal behavior in adults [12,13]. Furthermore, in a
previous microarray study we were able to characterize
whole-genome gene expression in FA animals, 96 hours
after preconditioning which is just before birth [11]. Now,
we aim to investigate the short- and long-term genomic
response to PA, and perinatal asphyxia when preceded by
fetal preconditioning (FAPA). We hypothesize that thening. A1-3: Control. B1-3: Perinatal asphyxia (PA) alone. C1-3: Fetal
w at 4x magnification. A2, B2, C2: Dentate gyrus at 10x magnification.
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pattern different from control and PA animals. Further-
more, we chose to take our microarray data-analysis be-
yond the single-gene approach, and subjected our data to
pathway analysis in order to derive results with maximum
biological relevance [14].
Results
Fetal preconditioning protects against abnormal
apoptosis in DG
Figure 1 depicts representative photomicrographs of the
Cleaved Caspase-3 staining. We observed no difference
in activated Caspase-3 signal intensity the CA1 hippo-
campal region in P14 animals. However, in the dentate
gyrus (DG) we observed a significant difference in acti-
vated Caspase-3 signal intensity with one-way ANOVA
(p = 0.014), and post-hoc Bonferroni tests showed an in-
crease of activated Caspase-3 signal intensity in the PA
group compared to the control animals (111,5% com-
pared to control, p < 0.05). No significant difference was
observed for the preconditioned FAPA group, indicating
functional fetal preconditioning.
Whole genome expression profiling
Whole-genome microarray technology was used to evalu-
ate differential gene expression in animals that underwent
FA, PA, or FAPA compared to controls, 6 and 96 hours
after birth. Results are depicted in a Venn diagram inFigure 2 Differential mRNA expression. This Venn diagram displays the
compared to controls, including the number of up- and downregulated tra
subjected to fetal preconditioning. PA: experimental group only subjected
preconditioning and perinatal asphyxia).Figure 2. At 6 hours after birth we found the majority of
differentially regulated genes in the FAPA group (517; 135↓
382↑), then in the FA group (402; 202↓ 200↑), and finally
in the PA group (204; 75↓ 129↑). At 96 hours after birth
we see a different picture with the majority of differentially
regulated genes in the FA group (324; 215↓ 109↑), then in
the FAPA group (176; 86↓ 90↑), and finally in the PA group
(145; 79↓ 66↑). The percentage of transcripts that are regu-
lated in two (0.6-24%) or all three (0.3-25%) experimental
groups is minimal, which leads us to conclude that the
transcriptional phenotype of these groups is unique.
In order to derive the neuroprotective mechanisms that
are active in the preconditioned brain and accomplish a
better outcome when subjected to asphyxia, studying the
effect of PA and FAPA will be most valuable. Therefore,
we will focus our results on further evaluation of the PA
and FAPA group.Effect of asphyxia on gene expression
Gene expression analysis with the Bioconductor Limma
package yielded 204 transcripts that were differentially
expressed in PA animals compared to control 6 hours
after perinatal asphyxia with a p-value <0.01, and fold
changes ranging from 0.67 to 1.46 (complete list available
in Additional file 1). We found 129 transcripts that were
upregulated, and 75 transcripts that were downregulated
6 hours after PA.number of differentially expressed transcript per experimental group
nscripts, at 6 and 96 hours after birth. (FA: experimental group only
to perinatal asphyxia. FAPA: experimental group subjected to both fetal
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cording to their biological function (see Figure 3A). After
asphyxia alone there is a marked upregulation of tran-
scripts involved in the cellular stress response (Ddit3,
Dnajb9, Hap1, Hspa13, Hspa5, Mt1a, Mt2a, RGD1561381,
Sh3pxd2a, Txnl4b). Also, many upregulated transcripts
are related to cell signaling pathways (Aktip, Dennd3,
Ebpl, Galntl1, Gfra1, Gnb5, Gprasp2, Hcrtr2, Inpp1,
Inpp5j, Limk2, Ppapdc1b, Rab22q, Rab24, Rab5a, Ras-
gef1c, Tmub2, V1re7). Furthermore, most differentially
expressed transcripts have their function in the cellFigure 3 Differential expression grouped according to biological func
columns while the number of downregulated transcripts is depicted by the
respectively. C-D: 96 hours after birth PA and FAPA group respectively. (PA
experimental group subjected to both fetal preconditioning and perinatalnucleus with the majority of these transcripts downregu-
lated (Upregulated: Abt1, Jund, LOC100125368, Nap1l5,
Pms2, Rbm11, Rexo4, Sfrs2ip, Swap70, Tspyl2, Zcchc12,
Zfp385d, Znf763. Downregulated: Ccna2, Cenpe, Fancg,
Helt, Hist2h2ac, Mcm4, Mzf1, Nfatc3, RGD1564126, Six2,
Taf7l, Zdhhc25, Zfp36l3).
Among the genes that were exclusively regulated in the
PA experimental group 6 hours after birth is the coiled-
coil domain containing 8 (Ccdc8) which was downregu-
lated after PA and known to be specifically required for
p53-mediated apoptosis after DNA damage [15].tion. The number of upregulated transcripts is depicted by the red
green columns. A-B: 6 hours after birth, PA and FAPA group
: experimental group only subjected to perinatal asphyxia. FAPA:
asphyxia).
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transcripts was decreased to 145, with a p-value <0.01 and
fold changes ranging from 0.72-1.59 (complete list avail-
able in Additional file 2). We found 66 transcripts that
were upregulated, and 79 transcripts that were downregu-
lated 96 hours after PA. Differentially expressed tran-
scripts were grouped according to their biological
function (see Figure 3C). The majority of upregulated
transcripts has their function in the cell nucleus (Khdrbs2,
Med1, Mllt3, Smarca2, Znf512), while the majority of
downregulated transcripts is involved in cell signaling
(Ak7, Evi2a, Gnal, Gng7, Gpr124, Itpka, Npy5r, Olr715,
Olr880, Rab15, Rasgrp1, Rasip1, Rasl10b, Spa17, Sulf2,
Taar7b) and cellular stress (Cant1, Cbs, Dnajc27, Mx1,
Nkiras1, Nqo1, Parp12). Interestingly, among the genes
related to cellular stress that were downregulated, 4 were
exclusively regulated in the PA group (Cant1, Mx1,
Nkiras1, Parp12). Moreover, the direction of transcrip-
tional regulation 96 hours after PA is opposite to our find-
ings 6 hours after PA for the following categories: “cell
nucleus”, “cell signaling”, and “cellular stress”.
Effect of asphyxia on gene expression in
preconditioned animals
With whole-genome microarray 6 hours after PA we
found 517 transcripts that were differentially expressed in
FAPA animals compared to control, with a p-value < 0.01,
and fold changes ranging from 0.62 to 1.95 (complete list
available in Additional file 1). With 382 transcripts the
majority of differentially expressed transcripts were upreg-
ulated. There were 135 downregulated transcripts in
FAPA animals 6 hours after PA. An overview of differen-
tially expressed transcripts grouped to biological function
can be found in Figure 3B. The majority of upregulated
transcripts have a function in the cell nucleus (Upregu-
lated: Abt1, Adar, Arid5b, Atf4, Casc3, Cdkl1, Chd2,
Cstf2t, Deadc1, Erg, Eya4, Gnl3, Hdac1, Hdac11,
LOC100125368, Mbnl2, Mir29c, Morc2, Morg1, Nap1l5,
Nr2c1, Prmt8, Prpf38b, Rfc2, Sfrs3, Taf1a, Tarsl2, Tspyl2,
Tspyl5, Xbp1, yars, Zbtb25, Zbtb26, Zcchc12, Zfp110,
Zfp143, Zfp235, Zfp385b, Zfp385d, Zfp397os, Zfp9, Zfr,
Zmym1, Znf23, Znf507, Zswim3, Zwilch) or are involved
in cell signaling (Upregulated: Acvr1b, Adap2, Adra1a,
Aktip, Alkp1, Arfrp1, Arhgap10, Arl1, Arrdc4, Eltd1,
Galnt11, Galnt14, Gfra1, Gprasp2, Grem1, Gtbpb8,
Hcrtr1, Inpp1, Inpp5j, Olr1148, Olr121, Pde3a, Pde8b,
Psd2, Rab24, Rab5a, Rasgef1c, Rasl11b, Rem2, Rerg, Rhoq,
V1rf5, V1rg13, Vom2r66). Furthermore, we found that
many upregulated transcripts play a role in cellular stress
(Clec2g, Ddit3, Derl3, Dnajb3, Dnajb9, Gstm5, Hap1,
Herpud1, Hif3a, Hspa13, Hspa5, Hspb1, Hyou1, LOC
289614, Mgst2, Mt2a, Nfkbie, Nucb2, Ppp1r15b, Selk,
Sels, Serp1, Tmx1, Txndc11, Txnl4b) and metabolism
(Aadacl1, Abo, Acadm, Aldh18a1, Aldh1l2, Aloxe3,Ampd3, Asns, Aspa, B3galt5, Blvra, Comtd1, Cyp1b1,
Fpgt, Gpd1, Gpt1, Mthfd2, Nus1, Osbp2, Pfkp, Phyhipl,
Pla1a, RGD1565316, Sat1).
Among the transcripts that were exclusively regulated
in FAPA animals 6 hours after PA there were many
genes with their function in the cell nucleus. Interest-
ingly, several of these are histone deacetylases (HDACs)
which are enzymes known to remove acetyl groups from
histone tails allowing the chromatin to wrap the DNA
more tightly and thereby repress gene expression [16].
Another group of genes exclusively regulated in FAPA
animals is related to the extracellular matrix and pos-
sibly the blood-brain barrier more specifically: integrins,
neurexophilin and embigin.
96 Hours after PA the number of differentially expressed
transcripts in preconditioned animals with a p-value <0.01
was decreased to 176, and fold changes ranging from 0.59
to 1.33 (complete list available in Additional file 2). There
were 90 upregulated transcripts and 90 downregulated
transcripts. An overview of differentially expressed tran-
scripts grouped to biological function can be found in
Figure 3D. The majority of differentially transcripts were
involved in cell signaling (Upregulated: Gpr33, Gpr87,
Gpr153, Gtpbp3, Olr522, Olr731, Olr1162, Olr1417,
Olr1584, Olr1730, Tas2r124. Downregulated: Ebpl, Gnal,
Gng7, Rgs18, Saps2, Tbc1d5, Tbc1d9b) or has a function
in the cell nucleus (Upregulated: Brd9, Cep152, Exosc7,
Hnrnpu, Hnrpd, Hoxc6, Lhx9, Nr0b2, Rnf213, Znf512.
Downregulated: Cdyl, Gemin7l1, Kat2a, Sc65, Znf622).
Among the genes exclusively regulated in FAPA animals
are 6 transcripts related to mitochondrial function
(Acadvl, Akr1c2, Atp5l, Chchd6, LOC691211, Ndufa2),
which were all downregulated. Furthermore, we observed
that at 96 hours after birth the transcripts with a function
in ubiquitination pathway are exclusively regulated in
FAPA animals.Validation of microarray results with RT-qPCR
Both on 6 hours and 96 hours after birth we randomly
chose 4 transcripts with a significant result in microarray
analysis for technical validation with RT-qPCR (see Table 1).
We observed greater fold changes with RT-qPCR compared
to microarray results which is a common finding [17].
At 6 hours after birth we observed upregulation of
Fkbp14 in FAPA compared to PA with qPCR (p < 0.05)
and similarly with microarray. An upregulation in FAPA
compared to control was observed for Arid5b (p < 0.05)
which is consistent with microarray findings. Similarly, up-
regulation in FAPA compared to PA was observed for
Hspb1 (p < 0.05) which is consistent with microarray find-
ings. Downregulation of PA compared to control and was
found for Cma1 with qPCR (p < 0.05) similar to microarray
results. The upregulation in FAPA compared to control for
Table 1 RT-qPCR validation of microarray findings
Time-point after birth Transcript Experimental group FC microarray P-value microarray FC P-value
RT-qPCR RT-qPCR
6 h Fkbp14 FAPA vs PA 1.20 p < 0.01 1.34 p < 0.05
Arid5b FAPA vs C 1.22 p < 0.0001 1.87 p < 0.05
Hspb1 FAPA vs PA 1.29 p < 0.001 1.46 p < 0.05
FAPA vs C 1.19 p < 0.001 1.39 p > 0.05
Cma1 PA vs C 0.82 p < 0.01 0.66 p < 0.05
FAPA vs PA 1.20 p < 0.01 1.45 p > 0.05
96 h Bloc1s2 FAPA vs C 0.78 p < 0.001 0.40 p < 0.01
Rdh10 PA vs C 0.87 p < 0.001 0.63 p < 0.05
Nkiras1 PA vs C 0.84 p < 0.001 0.66 p < 0.05
Sc65 FAPA vs C 0.66 p < 0.01 0.46 p < 0.001
FAPA vs PA 0.68 p < 0.01 0.65 p < 0.05
(PA: experimental group only subjected to perinatal asphyxia. FAPA: experimental group subjected to both fetal preconditioning and perinatal asphyxia).
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Cma1 could not be confirmed with qPCR.
At 96 hours after birth we observed downregulation in
PA compared to control for Nkiras1 and Rdh10 with
qPCR (p < 0.05) which is consistent with microarray re-
sults. Downregulation in FAPA compared to control was
found for Bloc1s2 and Sc65 (p < 0.01, p < 0.001), similar to
what we observed with the microarray. Furthermore, we
confirmed downregulation of Sc65 in FAPA compared to
PA with qPCR (p < 0.05).
Changes in biological pathways: gene set enrichment analysis
In order to derive results with maximum biological rele-
vance we decided to subject our data to a pathway based
approach. The method we used was Gene Set Enrichment
Analysis (GSEA) for which the entire data set was ranked
according to moderate t-statistics.
At 6 hours after birth we observed significant enrich-
ment of 6 gene sets which can be found in Table 2. The
KEGG pathway ‘protein processing in endoplasmatic
reticulum’ was upregulated in both PA and FAPA animals
compared to control. Another gene set related to the endo-
plasmatic reticulum (ER) is the KEGG pathway ‘N-glycan
biosynthesis’ which is only upregulated in the FAPA group.
N-glycans are very important for proper protein folding in
the ER, they have binding residues for chaperone proteins,
and they are known to be upregulated in the unfolded pro-
tein response [18]. This unfolded protein response has also
been demonstrated shortly after transient global ischemia
[19]. Furthermore, we observed upregulation of the KEGG
pathway ‘aminoacyl-tRNA biosynthesis’ in the FAPA
group. Similarly, a study of ischemia preconditioning in the
rat retina found upregulation of genes with aminoacyl-
tRNA synthetase activity [20]. Finally, in FAPA animals we
observed upregulation of the Krüppel associated box
(KRABbox) domain which is present in many zinc fingertranscription factors and has been shown to be effective
repressors of transcription [21]. One gene set is downregu-
lated 6 h after birth in FAPA and this is the KEGG pathway
‘steroid biosynthesis’. Interestingly, steroid administration
has previously been shown to aggravate neonatal hypoxic-
ischemic brain injury [22]. Similarly, a drug that suppresses
steroid biosynthesis was shown to prevent excitotoxic
injury in cortical neurons [23].
At 96 hours after birth we found 12 gene sets that were
significantly regulated in one or both experimental groups
when compared to controls. Two gene sets involved in
mitochondrial respiration, and more specifically the elec-
tron transport chain, were downregulated in both PA and
FAPA animals. When looking at the leading edge analysis
of these gene sets we observed that this downregulation
mainly involves mitochondrial complex I (NADH dehydro-
genase [ubiquinone]) and IV (cytochrome c oxidase) spe-
cific enzymes. This inhibition of mitochondrial complex I
and IV, irrespective of ischemic preconditioning, was previ-
ously shown in global ischemia in adult rats [24]. Further-
more, we also observed genes involved in mitochrondrial
complex II (succinate dehydrogenase), mitochondrial
complex III (ubiquinol cytochrome c reductase) and mito-
chondrial complex V (ATP synthase) within both of the
downregulated gene sets. Downregulation of these mito-
chondrial respiratory complexes can be beneficial following
cerebral hypoxia-ischemia because they are the main source
of Reactive Oxygen Species (ROS) in reperfusion [25]. Only
in the PA group we observed downregulation of three GO
terms related to neurotransmitters and synaptic transmis-
sion. Furthermore, the KEGG pathways ‘Calcium signaling
pathway’, ‘Salivary secretion’, and ‘Purine metabolism’ are
exclusively downregulated in PA animals and contain genes
that have a function in cellular signaling such as adenylate
cyclase, calmodulin, calcium/calmodulin-dependent protein
kinase, ATPase, protein kinase A, and protein kinase C.
Table 2 Gene Set Enrichment Analysis (GSEA) results
Time of sacrifice Gene set name Description NES FDR q-value Direction Experimental group
6 h KEGG:04141 Protein processing in endoplasmatic reticulum 2.54 <0.001 ↑ PA and FAPA
PF01352 KRABbox 2.42 <0.001 ↑ FAPA
PF00956 Nucleosome assembly protein 2.14 <0.01 ↑
KEGG:00970 Aminoacyl-tRNA biosynthesis 2.47 <0.001 ↑
KEGG:00510 N-glycan biosynthesis 2.04 <0.01 ↑
KEGG:00100 Steroid biosynthesis -2.58 <0.001 ↓
96 h GO:0005746 Mitochondrial respiratory chain -2.20 <0.01 ↓ PA and FAPA
KEGG:00190 Oxidative phosphorylation -2.34 <0.001 ↓
GO:0001505 Regulation of neurotransmitter levels -2.22 <0.01 ↓ PA
GO:0007268 Synaptic transmission -2.11 <0.01 ↓
GO:0007269 Neurotransmitter secretion -2.23 <0.01 ↓
KEGG:04020 Calcium signaling pathway -1.97 <0.01 ↓
KEGG:04970 Salivary secretion -2.16 <0.01 ↓
KEGG:04971 Purine metabolism -2.04 <0.01 ↓
PF00089 Trypsin 2.23 <0.01 ↑ FAPA
GO:0019208 Phosphatase regulator activity -2.09 <0.01 ↓
KEGG:03010 Ribosome -2.237 <0.001 ↓
BIOCARTA_PGC1APATHWAY -2.09 <0.01 ↓
Significantly enriched gene sets found with GSEA using the FDR q-value <0.01 as cut-off for significance. NES = Normalized Enrichment Score. FDR q-value = False
Discovery Rate method of correction for multiple testing. (PA: experimental group only subjected to perinatal asphyxia. FAPA: experimental group subjected to
both fetal preconditioning and perinatal asphyxia).
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tion of the KEGG pathway ‘Ribosome’ which includes
many ribosomal proteins and an ubiquitin residue. A pre-
vious study observed abnormal protein aggregation in
transient cerebral ischemia resulting in irreversible
destruction of protein synthesis machinery. Interestingly,
this abnormal protein aggregation was prevented in pre-
conditioned animals, and the downregulation of ribosomal
gene expression we observed here could explain this
phenomenon [26]. Finally, exclusively in FAPA we ob-
served upregulation of the ‘Trypsin’ gene set which in-
cludes many different proteases, mainly serine proteases.
Discussion
Here we present the first whole-genome expression data
in neonatal brain tissue after PA and PA preceded by
fetal preconditioning (FAPA). Following PA, we observed
a gene expression pattern in preconditioned animals that
differs significantly from control and PA animals.
From univariate to pathway analysis
We chose to take our microarray data analysis beyond the
single-gene approach in order to derive results with max-
imum biological relevance. Analyzing microarray results is
typically done by comparing genes on a gene-by-gene basis
and assessing if these genes are differentially expressed be-
tween experimental groups. Using this univariate approachthe focus is on the genes that show the largest difference in
expression between the experimental groups. However,
there are some vital limitations to this approach. Most
importantly univariate analysis assumes that all genes act
independently of one another, and this is not the case in
cell biology. It is well known that biological processes often
affect sets of genes that act simultaneously. Therefore, a
small increase in all genes that belong to a certain pathway
is likely to be more biologically relevant then a high
increase in a single gene in that pathway [27]. In addition,
with pathway analysis added to the standard analysis of
microarray data it is likely that we will find better overlap
in results when different studies are investigating the same
model [14]. There are many different methods available to
conduct pathway analysis with microarray data. We chose
Gene Set Enrichment Analysis (GSEA) in favor of a
Singular Enrichment Analysis (SEA), such as DAVID,
because GSEA does not require any pre-selection of genes
and thereby avoids arbitrary factors needed for pre-
selection. Moreover, because GSEA uses all information
obtained in a microarray experiment it is best suited to
allow genes with minimal changes to contribute to the
enrichment analysis [27].
Interestingly, GSEA results revealed a similar, but
more extensive perspective than our Limma analysis
results. Both indicate that the most upregulated genes
were involved in processes within the cell nucleus, and
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signal transduction and synaptic transmission. However,
GSEA provided more information on the pathways that
are involved.
Differential mRNA expression
When comparing the number of differentially expressed
transcripts among the different experimental groups we
notice that the FA group has the largest number of differ-
entially expressed transcripts. This was surprising since in
previous studies, where we performed behavioral tests at
6 months of age, FA animals score similar to control [12].
However, a study of focal ischemic preconditioning in
adult mice had similar results with the largest number of
differentially regulated transcript in the preconditioning
only group [8].
For a further description of the data we chose to focus
on the PA and FAPA experimental groups because both
underwent the injurious PA and our aim was to show how
the FAPA animals differ in their response to hypoxia-
ischemia in order to derive the neuroprotective mecha-
nisms that are in place after fetal preconditioning. The
differential gene expression pattern in FAPA animals is a
result of preconditioning-induced gene expression and PA-
induced gene expression; moreover, preconditioning can
also prevent the upregulation of certain PA-induced genes.
Interestingly, when we look at our results 96 hours
after birth we observe that still over a hundred tran-
scripts are differentially expressed in both PA and FAPA
groups. This suggests that the transcriptional response
to PA and fetal preconditioning is a durable one.
Finally, we need to be aware that it is mRNA expression
we are investigating and although this can give great
insight into cellular biology, gene expression does not
necessarily translate into protein expression. We need to
consider the facts that ischemia can both decrease protein
production [28], and that hypoxic conditions can increase
the stability of mRNA for specific transcripts which could
lead to false positives [29].
Cellular stress response is different in preconditioned animals
Interestingly, when comparing genes that are exclusively
expressed in respectively the PA and FAPA groups 6 hours
after birth we observe that FAPA animals show clearly
more differentially expressed transcripts (29 vs 15) related
to cellular stress. Exclusively in PA animals we observe an
upregulation of several genes known to be induced by
oxidative stress such as coiled-coil domain-containing 8
(Ccdc8) which plays a role in p-53 mediated apoptosis
after DNA damage, and sequestosome 1 (Sqstm1) which
is an ubiquitin binding protein involved in oxidative stress
and autophagy. In both groups we see upregulation of
metallothionein 2a (Mt2a) which is thought to protect
cytosolic creatine kinases against stress by oxidants [30].Although we see an upregulation of transcripts related to
the antioxidant thioredoxin (Txndc11, Txnl4b) in both
groups, the activation of antioxidants is clearly more
pronounced in the FAPA group. We observed upregula-
tion of antioxidants such as selenoproteins, glutathione
S-transferase, and thioredoxin-related transmembrane
protein (Tmx1, Selk, Sels, Mgst2, Gstm5) in FAPA ani-
mals 6 hours after birth. Moreover, we observe an upregu-
lation of NF-kappaB inhibitor epsilon (Nfkbie) in FAPA
animals. Nfkbie is known to trap Nfkb in the cytoplasm to
prevent it from activating genes in the nucleus [31]. Acti-
vation of the alpha subtype of NF-kappaB inhibitors has
been proposed to be modulated by nitric oxide and was
shown reduce neuronal damage following focal cerebral
ischemia [32]. Similarly, treatment with palmitoylethano-
lamide in transient ischemia was shown to inhibit degrad-
ation of the alpha subtype of NF-kappaB inhibitors and
convey neuroprotection [33]. Although the epsilon sub-
type of NF-kappaB inhibitors (Nfkbie) has not been stud-
ied in cerebral ischemia, our data together with previous
studies for different inhibitor of NF-kappaB subtypes
suggest it could be a promising target for further study.
The importance of ubiquitination and proteolysis
At 6 h after birth we see an upregulation of 2 transcripts
related to ubiquitination in both groups, but these are
not the same. In the PA group we observe upregulation
of Fbxo6 and Psma3, while in FAPA animals we observe
upregulation of Fbxo3 and Fbxo32. These transcripts
mainly belong to the F-box family which is a crucial
component of the Skp, Cullin, F-box containing complex
(SCF complex) which besides it role in ubiquitination
has an important role in cell cycle progression. Interest-
ingly, at 96 h after birth genes related to ubiquitination
are exclusively regulated in FAPA group (Uqcrq, and
March2 down, Ube2q2l up). There is increasing evidence
for the crucial importance of ubiquitination and subse-
quent proteolysis in oxidative stress and ischemia [34]. Still,
experimental evidence can seem contradicting when in a
model of isoflurane preconditioning neuroprotection is ac-
companied by attenuation of ubiquitin-conjugated protein
aggregates [35], and in a different study intravenous treat-
ment with ubiquitin was found to be neuroprotective [36].
Congruently with the upregulation of ubiquitin related
transcripts in the FAPA group, we observed upregulated of
transcripts involved in proteolysis and similarly with GSEA
we observed significant upregulation of a gene set (PF:
Trypsin) that comprises many proteases. Proteases are the
effectors of proteolysis and therefore protein degradation.
Ischemia leads to ER stress and protein misfolding.
Furthermore ischemia is known to damage protein degrad-
ation pathways which altogether results in aggregation of
unfolded proteins, translational arrest and ultimately cell
death. Our findings of upregulated proteases in the
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mic postconditioning where an increased proteasome
activity was found, as well as the observation that ischemic
tolerance is blocked by proteasome inhibitors [34].Involvement of epigenetic mechanisms
We observed a striking number of differentially regulated
transcripts with a function in the cell nucleus. The major-
ity of transcripts related to the cell nucleus are regulated
6 hours after birth in FAPA. Here, we observe an upregu-
lation of 50 transcripts, while 21 are downregulated. Many
of these belong to the zinc finger family of transcription
factors which were once considered function exclusively
as sequence-specific DNA-binding motifs but are increas-
ingly known for other functions such as their protein
binding abilities [37]. The induction of zinc fingers in
cerebral ischemia has been previously described but
unfortunately their role in ischemia or neuroprotection
has not been studied [38]. Besides differential regulation
of zinc fingers we observe differential expression of several
histone deacetylases (Hdac1, Hdac10, and Hdac11) exclu-
sively in the preconditioned FAPA group. HDACs are
enzymes that have the ability to remove acetyl groups
from histones thereby repressing gene expression [39].
This suggests that there might be epigenetic mechanisms
involved in preconditioning-induced neuroprotection,
which is consistent with our findings in prenatal brain
96 hours after fetal preconditioning alone [11]. Similarly,
in a recent review epigenetic changes were suggested to
be the ‘master switch’ for activating neuroprotective path-
ways after preconditioning [40]. Even though there is
growing evidence for a role of epigenetic mechanisms in
neuroprotection, the evidence today is contradictory re-
garding the mechanisms of action. For example, different
types of HDAC family members seem to exert different
functions in mediating neuroprotection, and may cause
different responses in different cell types. Additionally, we
need to keep in mind that besides their ability to modulate
chromatin, HDACs can also exhibit non-histone effects
such as acetylation of transcription factors [41]. Further-
more, besides the ability to modify proteins, such as
histones and transcription factors, it is important to
realize that HDACs themselves can be modified posttran-
slationally [16].
Another finding that indicates the involvement of epi-
genetic mechanisms is the upregulation of the KRAB-box
protein domain which is found with GSEA exclusively in
FAPA animals 6 hours after birth (see Table 2). We have
already mentioned how the KRAB domain is an effective
gene repressor but it is the ability to induce reversible het-
erochromatization which clearly links it to epigenetic
mechanisms. Similarly, the KRAB domain has been shown
to induce de novo promoter methylation, albeit irreversiblegene silencing, when generated in the first few days of
mouse development [42].
Altogether, our results lend support for more in-depth
research of epigenetic mechanisms involved in neuro
protection.
Conclusions
This study is the first to investigate whole-genome tran-
scription in the neonatal brain after PA alone and when
preceded by fetal asphyctic preconditioning.
After perinatal asphyxia alone we found that the majority
of differently regulated transcripts were upregulated in the
early phase. A great deal of these upregulated transcripts is
involved in the cellular stress response and cell signaling,
which makes our findings consistent previous microarray
research where different model approaches were used, and
at the same time lends validity to previous findings . In
addition we describe several genes and pathways, such as
ubiquitination and proteolysis, which were not previously
linked to preconditioning and/or neuroprotection.
Finally, we found that the majority of upregulated genes
in preconditioned animals have a function in the cell nu-
cleus, including several epigenetic players such as HDACs,




All experiment protocols were approved by the Animal
Ethics Board of Maastricht University according to Dutch
governmental regulations. Adult Sprague-Dawley rats (body
weight 250-320 g), obtained from Charles River (France),
were kept under standard laboratory conditions with food
and water given ad libitum, 21 ± 2˚C environment tempera-
ture, a 12 h light/dark schedule (lights on at 07:00 h) and
background noise provided by radio. Breeding and fetal
asphyctic (FA) preconditioning was carried out as previ-
ously described [11]. In brief, FA preconditioning was in-
duced on E17 by completely clamping both uterine and
both ovarian arteries with removable clamps for 30 minutes.
Control dams were left undisturbed until day E21. On E21
all pregnant dams were observed for signs of labor, and
after vaginal delivery of the first pup the mother was
decapitated and the uterus was removed by Caesarean
section. For PA and FAPA offspring, the uterus still
containing the unborn pups was immediately placed in a
water bath at 37°C for exactly 19 minutes to induce PA.
Subsequently, pups were removed from the uterine horns,
cleaned with gauze swabs and stimulated to breath inside
a pediatric incubator (37°C, 60-80% humidity, room air).
Finally, pups were randomly cross-fostered to surrogate
dams. In this study we used male offspring exclusively
because both morphological and behavioral evidence show
a differential vulnerability to a birth insult in males versus
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possibly due to the difference in circulating sex hormones
compared to females [43].
Tissue preparation
An overview of the experimental design is depicted in
Figure 4. Pups were sacrificed by decapitation at two dif-
ferent time-points: 6 and 96 hours after birth. We chose
these time-points in order to investigate the early and
late transcriptional response respectively.
For microarray analysis, left hemispheres were dissected
and submerged in RNA stabilizing reagent (Qiagen Benelux
BV, Venlo, The Netherlands) before being snap-frozen in
liquid nitrogen, and ultimately stored at -80°C. To prevent
litter effects only 1 pup per dam was used for microarray
analysis, with n = 5 per condition.
For RT-qPCR analysis right hemispheres were dis-
sected, snap-frozen in liquid nitrogen, and ultimately
stored at -80°C. A maximum of two pups per dam were
used for and RT-qPCR (n = 5-8).
Assessment of apoptosis
Complete brains of P14 animals were dissected and fixated
by immersion in paraformaldehyde-based fixative contain-
ing glutaraldehyde (20% paraformaldehyde, 25% glutaral-
dehyde in 0.2 M phosphate buffer containing 15% picric
acid) for 2 hours, before immersion in paraformaldehyde-
based fixative without glutaraldehyde for 10 days. After
immersion in 10% sucrose for 1 day, and 4 days in 20%
sucrose, brains were frozen with CO2 and stored at -80°C.
Frozen coronal sections (16 μm) were cut on glass slides
using a cryostate. After postfixation of 10 minutes in 4%
paraformaldehyde, sections were quenched in TBS con-
taining 3% hydrogen peroxide for 20 minutes, then
incubated in TBS containing 3% donkey serum, followed
by overnight incubation with anti-Cleaved Caspase 3Figure 4 Experimental design. (FA: experimental group only subjected to
perinatal asphyxia. FAPA: experimental group subjected to both fetal preco(Asp175, 1:5000, Cell Signalling Technology UK). The next
day, sections were incubated with secondary antibody for
2 hours (donkey anti-rabbit biotinylated, 1:200, Jackson
ImmunoResearch USA). Finally, sections were incubated
with avidin biotin complex (ABC reagent, 1:100, Vector
Labs UK) for 1 hour before staining was revealed using
3,3′diaminobenzidine (DAB, Vector Labs UK) for 10 mi-
nutes. Using an AX70 microscope (Olympus NL), photo-
micrographs were taken at 4x and 10x magnification with
Olympus Cell^P software version 5.1. Per animal, 3-5 sec-
tions were delineated between Bregma -3.14 and -4.30, and
for each delineation, the mean gray value was calculated in
ImageJ (version 1.45 s, NIH USA). Immunohistochemical
staining, delineation and gray value calculation were per-
formed in a blind fashion.
Microarray analysis
For microarray analysis total RNA extraction and purifica-
tion were performed on mini RNeasy columns (Qiagen
Benelux BV, Venlo, The Netherlands), according to the
manufacturer’s instructions. Quantity and purity of total
RNA was determined by spectrophotometer analysis using
the Nanodrop ND-1000 (Thermo Fisher Scientific Inc.,
Waltham, USA). Only samples with a 260/280 ratio
between 1.8 and 2.1, and a 260/230 ratio between 1.5
and 2.0 were selected for microarray analysis. Addition-
ally, RNA quality measurements were performed with
Bioanalyzer 2100 (Agilent Technologies Netherlands B.
V.). Samples with an RNA integrity number (RIN) below
8 were excluded.
Using the Ambion WT Expression Kit, per sample,
an amount of 100 ng of total RNA spiked with bacterial
poly-A RNA positive controls (Affymetrix Inc., Santa
Clara, USA) was converted to double stranded cDNA
in a reverse transcription reaction. Next, the sample
was converted and amplified to antisense cRNA in anfetal preconditioning. PA: experimental group only subjected to
nditioning and perinatal asphyxia).
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converted to single stranded sense cDNA. Finally, sam-
ples were fragmented and labeled with biotin in a ter-
minal labeling reaction according to the Affymetrix
WT Terminal Labeling Kit. A mixture of fragmented
biotinylated cDNA and hybridization controls (Affyme-
trix Inc., Santa Clara, USA) was hybridized on Affyme-
trix GeneChip Rat Gene 1.0 ST Arrays followed by
staining and washing in a GeneChip® fluidics station
450 (Affymetrix Inc., Santa Clara, USA) according to
the manufacturer’s procedures. To assess the raw probe
signal intensities, chips were scanned using a GeneChip®
scanner 3000 (Affymetrix Inc., Santa Clara, USA). Accord-
ing to MIAME requirements data were submitted the
NCBI GEO database, and are available under accession
number: GSE42676.
RT-qPCR
Total RNA was extracted with Trizol® reagent (Invitro-
gen, Paisley Scotland, UK) according to manufacturer’s
instructions. Next, cDNA was generated with RevertAid
First Strand cDNA synthesis kit (Fermentas GMBH, St.
Leon-Rot, Germany). RT-qPCR reactions were carried out
using SYBR green PCR master mix and the LightCycler
480 (Roche Diagnostics, Almere, The Netherlands). All
primers were designed using Primer-BLAST. To control
for error between samples we used the geometric mean
of Ywhaz, Rpl13a, ß-actin and Hprt1 for normalization.
We selected these reference genes based on their stabil-
ity across our experimental conditions. Sequences of all
primers used can be found in Table 3.
Gene Set Enrichment Analysis (GSEA)
For GSEA, a total of 737 rattus norvegicus gene sets
were assembled, including 196 KEGG pathways (release
59.0), 81 Biocarta pathways (accessed August 18th












Bloc1s2 5′- AACTGACAGCCACCAGand 276 Pfam protein families database (Pfam 25.0).
Each gene-set contained a minimum of 15 genes and a
maximum of 500 genes in accordance with GSEA rec-
ommendations. The analysis was conducted using the
GSEA software v2.07, provided by the Broad Institute
(Cambridge, MA, USA) [14]. Ultimately, we performed
a ‘Leading Edge Analysis’ in GSEA on significantly
enriched gene-sets, to identify the genes that contribute
most to the enrichment signal.
Statistics
Analysis of the microarray data was performed in the R
programming environment (version 2.12.0), with the
packages developed within the Bioconductor project.
The analysis was based on the RMA expression levels
of the probe sets. Differential expression was assessed
with the Limma package using moderated t-statistics.
Results are presented as fold changes compared to con-
trol, and p-values < 0.01 were considered statistically
significant.
For RT-qPCR, all data were distributed normally as
tested with Kolmogorov-Smirnov test. Statistical signifi-
cance was tested with the unpaired, two-tailed Student’s t-
test. Results are presented fold change, means + SEM, and
p-values <0.05 were considered statistically significant.
For GSEA, the microarray dataset was pre-ranked
using moderated t-statistics. A gene set enrichment
score (ES) was calculated based on Kolmogorov-
Smirnov statistics and for each gene set the ES was
normalized to account for difference in gene set size.
Finally, a false discovery rate (FDR) was calculated rela-
tive to the normalized enrichment score (NES) values
to determine the probability of type I errors. To control
for multiple testing we used the false discovery rate
(FDR) as described by Benjamin and Hochberg.
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